Return to PR archive




DURECT Reports Positive Phase IIb Data from POSIDUR(TM) Clinical Program

CUPERTINO, Calif.-

December 17, 2009

http://phx.corporate-ir.net/phoenix.zhtml?c=121590&p=irol-newsArticle&ID=1367063&highlight=
Return to PR archive


 
 © 2000-2010 DURECT Corporation
Last updated: July 29, 2010
Search     Contact     Site Index     Legal Notice     Privacy Policy